Literature DB >> 8476751

Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes.

M Akhtar1, V C Njar, J N Wright.   

Abstract

Some P-450 systems, notably aromatase and 14 alpha-demethylase catalyse not only the hydroxylate reaction but also the oxidation of an alcohol into a carbonyl compound as well as a C-C bond cleavage process. All these reactions occur at the same active site. A somewhat analogous situation is noted with 17 alpha-hydroxylase-17,20-lyase that participates in hydroxylation as well as C-C bond cleavage process. The C-C bond cleavage reactions catalysed by the above enzymes conform to the general equation: [formula: see text] It is argued that all three types of reaction catalyzed by these enzymes may be viewed as variations on a common theme. In P-450 dependent hydroxylation the initially formed FeIII-O-O. species is converted into FeIII-O-OH and the heterolysis of the oxygen-oxygen bond of the latter then gives the oxo-derivative for which a number of canonical structures are possible; for example FeV = O<==>(+.)FeIV = O<==>FeIV-O.. One of these, FeIV-O. behaves like an alkoxyl radical and participates in hydrogen abstraction from C-H bond to produce FeIV-OH and carbon radical. The latter is then quenched by the delivery of hydroxyl radical from FeIV-OH. The latter species may thus be regarded as a carrier of hydroxyl radical. We have proposed that the C-C bond cleavage reaction occurs through the participation of the FeIII-O-OH species that is trapped by the electrophilic property of the carbonyl compound giving a peroxide adduct that fragments to produce an acyl-carbon cleavage. Scientific developments leading up to this conclusion are considered. In the first author's views, "The study of mechanisms is not a scientific but a cultural activity. Mechanisms do not aim at an absolute truth but are intended to be a "running" commentary on the status of knowledge in a field. As the structural knowledge in a field advances Mechanisms evolve to take note of the new findings. Just as a constructive "running" commentary provides the stimulus for higher standards of performance, so Mechanisms call for better and firmer structural information from their practitioners".

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476751     DOI: 10.1016/0960-0760(93)90241-n

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  19 in total

Review 1.  Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.

Authors:  Debashis Ghosh; Jessica Lo; Chinaza Egbuta
Journal:  J Med Chem       Date:  2016-01-19       Impact factor: 7.446

2.  Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2006-11-15       Impact factor: 3.533

3.  An analysis of the role of active site protic residues of cytochrome P-450s: mechanistic and mutational studies on 17alpha-hydroxylase-17,20-lyase (P-45017alpha also CYP17).

Authors:  P Lee-Robichaud; M E Akhtar; M Akhtar
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

4.  Anaerobic mineralization of quaternary carbon atoms: isolation of denitrifying bacteria on dimethylmalonate.

Authors:  O Kniemeyer; C Probian; R Rosselló-Mora; J Harder
Journal:  Appl Environ Microbiol       Date:  1999-08       Impact factor: 4.792

5.  Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study.

Authors:  Roberta Galeazzi; Luca Massaccesi
Journal:  J Mol Model       Date:  2011-06-18       Impact factor: 1.810

Review 6.  Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

Authors:  S Palomba; F Orio; T Russo; A Falbo; T Cascella; A Colao; G Lombardi; F Zullo
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

Review 7.  Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.

Authors:  V C Njar; A M Brodie
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

8.  Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.

Authors:  Roman Davydov; Andrey A Gilep; Natallia V Strushkevich; Sergey A Usanov; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2012-10-05       Impact factor: 15.419

9.  Kinetic solvent isotope effect in steady-state turnover by CYP19A1 suggests involvement of Compound 1 for both hydroxylation and aromatization steps.

Authors:  Yogan Khatri; Abhinav Luthra; Ruchia Duggal; Stephen G Sligar
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

10.  Structural basis for androgen specificity and oestrogen synthesis in human aromatase.

Authors:  Debashis Ghosh; Jennifer Griswold; Mary Erman; Walter Pangborn
Journal:  Nature       Date:  2009-01-08       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.